KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

West Pharmaceutical Services (WST) Other Non-Current Assets (2016 - 2025)

West Pharmaceutical Services' Other Non-Current Assets history spans 17 years, with the latest figure at $80.1 million for Q4 2025.

  • For Q4 2025, Other Non-Current Assets rose 7.81% year-over-year to $80.1 million; the TTM value through Dec 2025 reached $80.1 million, up 7.81%, while the annual FY2025 figure was $80.1 million, 7.81% up from the prior year.
  • Other Non-Current Assets for Q4 2025 was $80.1 million at West Pharmaceutical Services, up from $75.8 million in the prior quarter.
  • Across five years, Other Non-Current Assets topped out at $80.1 million in Q4 2025 and bottomed at $14.6 million in Q1 2021.
  • The 5-year median for Other Non-Current Assets is $39.6 million (2023), against an average of $43.7 million.
  • The largest annual shift saw Other Non-Current Assets crashed 48.23% in 2024 before it soared 269.47% in 2025.
  • A 5-year view of Other Non-Current Assets shows it stood at $16.7 million in 2021, then skyrocketed by 129.94% to $38.4 million in 2022, then tumbled by 44.53% to $21.3 million in 2023, then soared by 248.83% to $74.3 million in 2024, then increased by 7.81% to $80.1 million in 2025.
  • Per Business Quant, the three most recent readings for WST's Other Non-Current Assets are $80.1 million (Q4 2025), $75.8 million (Q3 2025), and $70.5 million (Q2 2025).